• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. EQUINOXE SHOULDER SYSTEM; PROSTHESIS, SHOULDER, SEMI-CONSTRAINED, METAL/POLYMER CEMENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. EQUINOXE SHOULDER SYSTEM; PROSTHESIS, SHOULDER, SEMI-CONSTRAINED, METAL/POLYMER CEMENTED Back to Search Results
Device Problems Degraded (1153); Material Discolored (1170); Material Fragmentation (1261)
Patient Problems Failure of Implant (1924); Implant Pain (4561)
Event Type  Injury  
Event Description
(b)(6) underwent total shoulder replacement with the equinoxc implant on (b)(6) 2014.During the following years, she suffered continued pain in the shoulder and underwent exploratory surgery of the shoulder on (b)(6) 2022.The surgeon found that the glenoid portion of the implant was discolored and delaminating and that pieces of plastic had broken off the glenoid portion of the implant.The surgeon states that the glenoid portion of the implant will need to be replaced in the coming months.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EQUINOXE SHOULDER SYSTEM
Type of Device
PROSTHESIS, SHOULDER, SEMI-CONSTRAINED, METAL/POLYMER CEMENTED
Manufacturer (Section D)
EXACTECH, INC.
MDR Report Key15638467
MDR Text Key302197495
Report NumberMW5112747
Device Sequence Number1
Product Code KWS
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 10/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/19/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
CALCIUM; COLACE; FAMOTIDINE; LORAZEPAM; TUMERIC; VITAMIN B12; VITAMIN D
Patient Outcome(s) Other;
Patient Age66 YR
Patient SexFemale
Patient Weight50 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-